Arbiter Emerges From Stealth With $52 Million Seed Round to Build AI-Powered Healthcare Orchestration Platform

Arbiter, a health-tech startup developing an AI-powered care orchestration platform designed to connect patients, providers, and payers, has emerged from stealth with $52 million in seed funding at a reported valuation of $400 million. The unusually large seed round was co-led by TriEdge Investments and MFO Ventures, with participation from WindRose Health Investors and several healthcare-focused family offices, reflecting strong investor confidence in the company’s approach to addressing systemic inefficiencies in the U.S. healthcare system.

Founded by Michelle Carnahan, a former senior executive at Eli Lilly and president of healthcare company Thirty Madison, Arbiter was created to tackle the persistent fragmentation that characterizes healthcare delivery. The company’s platform is designed to serve as an “operating spine” for healthcare organizations, integrating clinical, financial, and administrative data into a unified system that can coordinate actions across stakeholders. By automating complex workflows that typically require manual intervention, Arbiter aims to reduce delays, administrative burden, and unnecessary costs across the care continuum.

Arbiter’s initial product focus is on real-time site-of-care optimization. The platform evaluates referrals and matches patients to the most appropriate care settings based on criteria such as quality, cost, and availability. At the same time, it automates downstream processes including prior authorizations, scheduling, and patient outreach. This orchestration is intended to ensure that patients receive timely care while providers and payers remain aligned on coverage and operational requirements.

The $52 million in seed funding will be used to accelerate product development, expand the company’s operational footprint, and deepen partnerships with payer organizations and provider networks. Arbiter plans to invest heavily in its engineering and data science teams to further develop its AI-driven automation capabilities. The company also intends to scale deployments with healthcare partners, building on early pilots that demonstrate how integrated workflows can reduce administrative overhead for clinicians and care teams.

Investors backing Arbiter bring extensive experience in healthcare operations, technology, and long-term company building. TriEdge Investments and MFO Ventures co-led the round, while WindRose Health Investors adds deep domain expertise in healthcare services and delivery. Arbiter has emphasized that its investor base was intentionally selected for operational knowledge and strategic alignment rather than short-term financial returns, a choice that reflects the company’s focus on solving complex, deeply embedded healthcare challenges.

Healthcare fragmentation remains a major contributor to rising costs and poor patient experiences, with disconnected systems often leading to lost referrals, delayed care, and duplicative administrative work. Arbiter’s platform is designed to address these issues by unifying data and automating decision-making across organizations that traditionally operate in silos. By creating a single source of truth for patient journeys, the company aims to reduce friction between payers and providers while improving visibility into care pathways.

Arbiter has already begun working with early customers, including payer and provider organizations, and reports that its platform is live with more than 1,000 clinicians. These early deployments are intended to validate the platform’s ability to operate at scale and integrate into existing healthcare workflows without disrupting clinical care. The company views this early traction as evidence that healthcare organizations are actively seeking solutions that can reduce administrative burden while improving coordination.

Michelle Carnahan has stated that Arbiter’s long-term vision is to move healthcare from a reactive system to one that is proactive and anticipatory. By leveraging artificial intelligence to coordinate actions in real time, the platform aims to ensure that patients receive the right care at the right time, while providers and payers operate more efficiently behind the scenes.

As Arbiter continues to expand its platform and customer base, the company is positioning itself as a foundational layer for healthcare orchestration. With significant seed funding, experienced leadership, and backing from healthcare-focused investors, Arbiter is seeking to redefine how care is coordinated across the U.S. healthcare system by using AI to align incentives, streamline workflows, and improve outcomes for patients and providers alike.